CT imaging features of patients infected with 2019 novel coronavirus

January 26, 2021

Announcing a new publication for BIO Integration journal. In this opinion article the authors Tianhong Yao, Huirong Lin, Jingsong Mao, Shuaidong Huo and Gang Liu from Xiamen University, Xiamen, China discuss CT imaging features of patients infected with 2019 novel coronavirus.

Novel coronavirus pneumonia is an acute, infectious pneumonia caused by a novel coronavirus infection. Computed tomographic (CT) imaging is one of the main methods to screen and diagnose patients with this disease. In this article the authors discuss the importance and clinical value of chest CT examination in the diagnosis of COVID-19, and the pulmonary CT findings of COVID-19 patients in different stages are briefly summarized, providing a reference document for the CT diagnosis of COVID-19 patients.
-end-
Article reference: Tianhong Yao, Huirong Lin, Jingsong Mao, Shuaidong Huo and Gang Liu, CT Imaging Features of Patients Infected with 2019 Novel Coronavirus, BIO Integration, 2021, https://doi.org/10.15212/bioi-2020-0038

BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

BIOI is now open for submissions; articles can be submitted online at: https://mc04.manuscriptcentral.com/bioi

Please visit http://www.bio-integration.org to learn more about the journal.

Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the IngentaConnect platform and at the BIO Integrationwebsite .

Submissions may be made using ScholarOne.

There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook and LinkedIn .

ISSN 2712-0074
eISSN 2712-0082


Keywords: Chest CT images, COVID-19, diagnosis stages, novel coronavirus pneumonia

Compuscript Ltd

Related Coronavirus Articles from Brightsurf:

Chemists discover the structure of a key coronavirus protein
MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus.

Plasma treatments quickly kill coronavirus on surfaces
Researchers from UCLA believe using plasma could promise a significant breakthrough in the fight against the spread of COVID-19.

Cornea appears to resist infection from novel coronavirus
Some doctors have worried that the novel coronavirus may be able to infect people by getting into their eyes.

Study provides clues on curbing the aggressive nature of coronavirus
Recent study by Estonian researchers in University of Tartu explains how coronavirus is activated before attacking the cell and what could help to impede that.

Coronavirus mutation may have made it more contagious
A study involving more than 5,000 COVID-19 patients in Houston finds that the virus that causes the disease is accumulating genetic mutations, one of which may have made it more contagious.

Scientists map structure of potent antibody against coronavirus
Scientists at Fred Hutchinson Cancer Research Center in Seattle have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus's distinctive spikes and induces critical pieces of those spikes to break off in the process.

Coronavirus volunteers: Greater satisfaction thanks to online platforms
Shortly after the lockdown began, a huge number of volunteers signed up to help people in coronavirus risk groups - primarily via online platforms.

Population currently sees coronavirus as the greatest health risk
The coronavirus is currently the population's main concern. More than a quarter of consumers perceive the virus as the greatest health risk.

Coronavirus: Study finds further door opener into the cell
The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2.

Repurposing drugs for a pan-coronavirus treatment
The study identifies drug targets common to all three coronaviruses (SARS-CoV-2, SARS-CoV-1, and MERS-CoV) and potential drugs that could be repurposed as COVID-19 treatments.

Read More: Coronavirus News and Coronavirus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.